Defective Fc‐dependent processing of immune complexes in patients with systemic lupus erythematosus
Open Access
- 5 April 2002
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (4) , 1028-1038
- https://doi.org/10.1002/art.10189
Abstract
Objective To explore the Fc receptor–dependent handling of immune complexes (ICs) by the fixed mononuclear phagocytic systems (MPS) in patients with systemic lupus erythematosus (SLE). Methods The processing in vivo of soluble model 123I–hepatitis B/ anti–hepatitis B ICs was studied in 12 healthy subjects and 10 patients with active SLE. ICs that fixed complement poorly were prepared specifically in order to explore Fc receptor–dependent clearance mechanisms. Clearance kinetics and organ uptake were assessed by computer‐aided gamma scintigraphy and serial blood sampling. Results In both patients and controls, the main site of IC clearance was the liver; only 2–6% of injected ICs were taken up in the spleen. The kinetics of initial IC clearance were similar in both groups, but defective hepatic retention of ICs was demonstrated in patients with SLE. At 1 hour, hepatic activity in patients had fallen to 56% of maximum, compared with 74% in controls (P = 0.0002). Precipitation studies performed on serum samples using staphylococcal protein A–Sepharose indicated that antibody‐complexed tracer was released from the liver 20–50 minutes after injection. Conclusion These results indicate that Fc‐mediated clearance of ICs is defective in patients with SLE and suggest that ligation of ICs by Fc receptors is critical for their efficient binding and retention by the fixed MPS in the liver.Keywords
This publication has 28 references indexed in Scilit:
- Overrepresentation of the Fc? receptor type IIA R131/R131 genotype in Caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritisArthritis & Rheumatism, 1999
- Fc? receptor IIa polymorphism in caucasian patients with systemic lupus erythematosus: Association with clinical symptomsArthritis & Rheumatism, 1998
- Antibodies to C1q in systemic lupus erythematosus: Characteristics and relation to FcγRIIA allelesKidney International, 1997
- Clinical significance of IgG Fc receptors and FcγR-directed immunotherapiesImmunology Today, 1997
- Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies.Journal of Clinical Investigation, 1992
- Immune adherence and clearance of hepatitis B surface Ag/Ab complexes is abnormal in patients with systemic lupus erythematosus (SLE)Clinical and Experimental Immunology, 1991
- Elimination of soluble 123I‐labeled aggregates of IgG in patients with systemic lupus erythematosus. Effect of serum IgG and numbers of erythrocyte complement receptor type 1Arthritis & Rheumatism, 1991
- Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus ErythematosusNew England Journal of Medicine, 1979
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- Studies on the In Vivo Effects of Antibody INTERACTION OF IgM ANTIBODY AND COMPLEMENT IN THE IMMUNE CLEARANCE AND DESTRUCTION OF ERYTHROCYTES IN MANJournal of Clinical Investigation, 1974